Skip to the page

Data / Public companies / SIC 2833: Medicinal chemicals and botanical products / Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings, Inc.: revenue, net income and total assets from its latest annual report

Updated March 12, 2026. Source: SEC Financial Statement Data Sets, filing 0001628280-26-017374.

Ascend Wellness Holdings, Inc. reported revenue of $500.6 million, a net loss of $118.2 million and total assets of $907.9 million for the fiscal year ended December 31, 2025, in its annual report (10-K) filed with the SEC on March 12, 2026. It ranks 6th by revenue of 30 companies in SIC 2833, medicinal chemicals and botanical products.

The request: Watch Ascend Wellness Holdings, Inc. (CIK 1756390): each new SEC filing, with revenue and net income. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.

SEC central index key (CIK)
1756390
Industry
SIC 2833, Medicinal chemicals and botanical products
Business address (city and state)
Morristown, New Jersey
Incorporated in
Delaware
Filer category
Non-accelerated filer
Fiscal year ends
December 31
Latest annual report
10-K filed March 12, 2026
Annual and quarterly reports in the data
1 annual, 4 quarterly

Financials for the fiscal year ended December 31, 2025

As filed, in US dollars. The prior year value is the comparison column in the same report.

ItemThis yearPrior yearChangeSource
Revenue$500,581,000$561,599,000-10.9%sec.gov
Operating income$-17,012,000Not listedNot listedsec.gov
Net income$-118,193,000$-84,994,000-39.1%sec.gov
Total assets$907,929,000$900,431,0000.8%sec.gov
Total liabilities$954,546,000Not listedNot listedsec.gov
Stockholders' equity$-47,440,000Not listedNot listedsec.gov
Cash and cash equivalents$85,676,000Not listedNot listedsec.gov

How it compares

Net margin (net income over revenue)
-23.6%
Revenue change on the prior year
-10.9%
Revenue rank in SIC 2833
6th of 30
Revenue rank in New Jersey
60th of 127
Revenue rank among all companies in the data
2,102nd of 4,486

Companies next to it by revenue in SIC 2833

Medicinal chemicals and botanical products, from the same data.

CompanyBusiness addressRevenueNet incomeTotal assetsRevenue change
Trulieve Cannabis Corp.Tallahassee, FL$1.18 billion$-122,248,000$2.70 billion-0.4%
USANA Health Sciences IncSalt Lake City, UT$925.3 million$10.8 million$742.9 million8.3%
Tilray Brands, Inc.New York, NY$915.5 million$-121,397,000$2.33 billion11.5%
Cresco Labs Inc.Chicago, IL$655.8 million$-135,408,000$1.20 billion-9.5%
Jushi Holdings Inc.Boca Raton, FL$262.9 million$-68,591,000$422.3 million2.1%
Biote Corp.Irving, TX$192.2 million$27 million$107.6 million-2.5%
Glass House Brands Inc.Long Beach, CA$182 million$-29,659,000$318.6 million-9.4%
Marimed Inc.Norwood, MA$159.8 million$-14,484,000$202.6 million1.3%

Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.